Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

22 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Bone Metastases NCT02226276

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02226276

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056

- 20-09-21 - 1 Formulier, 3 Itemgroepen, 53 Data-elementen, 1 Taal
Itemgroepen: Header, Randomization questions, Patient status assessment
Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159B9D6-FD84-2C7B-E034-0003BA3F9857

Eligibility DRKS00009676 NCT00321620 Bone Metastases - Eligibility

- 20-09-21 - 1 Formulier, 2 Itemgroepen, 10 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00321620

Southwest Oncology Group Registration Form (S0421) NCT00134056

- 20-09-21 - 1 Formulier, 3 Itemgroepen, 40 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Miscellaneous Patient Information
Southwest Oncology Group Registration Form (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A11DF-588A-2157-E034-0003BA3F9857

29877_Mirels Score of Pathologic Fracture Risk - Mirels Score of Pathologic Fracture Risk

- 14-05-18 - 1 Formulier, 1 Itemgroep, 5 Data-elementen, 2 Talen
Itemgroep: Mirels score
German title: "Frakturrisiko nach Mirels (zur Abschätzung der Wahrscheinlichkeit der notwendigen operativen Stabilisierung bei drohenden pathologischen Frakturen)". Reference: Mirels, H. (1989). Metastatic Disease in Long Bones A Proposed Scoring System for Diagnosing Impending Pathologic Fractures. Clinical orthopaedics and related research, 249, 256-264. Source: www.traumascores.com with permission from Dr. Müller. Sent by Mark Lenz and Kajetan Klos, Uniklinik Jena.

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases - Radium 223 Dichloride (Alpharadin) - Screening Visit

- 13-02-17 - 1 Formulier, 9 Itemgroepen, 89 Data-elementen, 1 Taal
Itemgroepen: Demography, Vital Signs, Prostate Cancer Classification, BPI-SF, ECOG Performance Status, Prior radiotherapy, Prior diagnostic and therapeutic procedures for prostate cancer, Hematology (with DBC), General chemistry - Serum
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form

- 28-07-15 - 1 Formulier, 5 Itemgroepen, 26 Data-elementen, 1 Taal
Itemgroepen: Header, STATUS, TREATMENT, ARM 1 + ARM 2, COMMENTS
SOUTHWEST ONCOLOGY GROUP S0421 TREATMENT FORM: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A78DC-93A4-2746-E034-0003BA3F9857

NCT00134056 Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 1 Randomization Form

- 05-07-15 - 1 Formulier, 3 Itemgroepen, 22 Data-elementen, 1 Taal
Itemgroepen: SWOG clinical trial administrative data, Form completed by, Comments
NCT00134056 Southwest Oncology Group S0421 Cover Sheet for Patient Completed Questionnaires: Step 1 Randomization Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B4D3C-6774-37C6-E034-0003BA3F9857

Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056

- 27-06-15 - 1 Formulier, 2 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: SWOG clinical trial administrative data, Patient demographics
Southwest Oncology Group Registration Form Step 2 (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F977EF7-B9B7-51FB-E044-0003BA3F9857

CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001

- 21-06-15 - 1 Formulier, 5 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Target Lesion(s) Baseline Evaluation, Non-target lesion(s) Baseline Evaluation, CCRR MODULE
CALGB: 90202 Baseline Solid Tumor Evaluation Form NCT00079001 Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4605F45-F7E1-0518-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056

- 12-06-15 - 1 Formulier, 3 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Header, Patient Instructions, Patient medical history
SOUTHWEST ONCOLOGY GROUP S0421 PAIN MEDICATION LOG AND PAIN ASSESSMENT: Step 2 Post-Chemo Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D64D5-FB3B-3049-E044-0003BA3F9857

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0421) NCT00134056

- 12-06-15 - 1 Formulier, 6 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: Header, TARGET LESIONS, NON-TARGET DISEASE, NEW LESIONS (specify site), Symptomatic deterioration, Comments
SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159E224-5826-3109-E034-0003BA3F9857

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial